DARRIN UECKER - 12 Jun 2025 Form 4 Insider Report for PULSE BIOSCIENCES, INC. (PLSE)

Role
Chief Technology Officer, Director
Signature
/s/ Kenneth B. Stratton, as Attorney-in-Fact
Issuer symbol
PLSE
Transactions as of
12 Jun 2025
Transactions value $
$-485,700
Form type
4
Filing time
16 Jun 2025, 20:23:49 UTC
Previous filing
03 Nov 2023
Next filing
15 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
UECKER DARRIN Chief Technology Officer, Director C/O PULSE BIOSCIENCES, INC., 3957 POINT EDEN WAY, HAYWARD /s/ Kenneth B. Stratton, as Attorney-in-Fact 16 Jun 2025 0001276311

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLSE Common Stock Sale $-246,000 -15,000 -9.81% $16.40 137,872 12 Jun 2025 Direct F1
transaction PLSE Common Stock Sale $-239,700 -15,000 -10.9% $15.98 122,872 13 Jun 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price in column 4 is the weighted average price per share sold. The price per share actually received by the Reporting Person ranged from $16.32 to $16.57 per share. For all transactions reported in this Form 4 using a weighted average price, the Reporting Person undertakes upon request by the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range.
F2 The price in column 4 is the weighted average price per share sold. The price per share actually received by the Reporting Person ranged from $15.90 to $16.04 per share. For all transactions reported in this Form 4 using a weighted average price, the Reporting Person undertakes upon request by the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range.